Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DownsLit: Lithium Carbonate in Down's Syndrome
2008-008342-20Phase 4Completed
- Sponsor
- King's College London
- Start
- Jul 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Down syndrome comparing Lithium carbonate (Camcolit) with Placebo (2 arms). Primary endpoint: Change in brain myo-inositol concentration. Started Jul 2009; status: completed.
02
Drugs
lithium carbonate
03
Conditions
Down syndrome
Beyond the preview
Go deeper on 2008-008342-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008342-20.